Revenues in USD of Dolby Laboratories, Inc. from Q1 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Dolby Laboratories, Inc. quarterly and annual Revenues history and change rate from Q1 2010 to Q2 2025.
  • Dolby Laboratories, Inc. Revenues for the quarter ending 27 Jun 2025 was $315,546,000, a 9.25% increase year-over-year.
  • Dolby Laboratories, Inc. annual Revenues for 2021 was $1,281,256,000, a 10.3% increase from 2020.
  • Dolby Laboratories, Inc. annual Revenues for 2020 was $1,161,792,000, a 6.43% decline from 2019.
  • Dolby Laboratories, Inc. annual Revenues for 2019 was $1,241,620,000, a 17.7% increase from 2018.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Dolby Laboratories, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $315,546,000 +$26,728,000 +9.3% 29 Mar 2025 27 Jun 2025 10-Q 31 Jul 2025 2025 Q3
Q1 2025 $369,561,000 +$5,038,000 +1.4% 28 Dec 2024 28 Mar 2025 10-Q 01 May 2025 2025 Q2
Q4 2024 $356,999,000 +$41,425,000 +13% 28 Sep 2024 27 Dec 2024 10-Q 30 Jan 2025 2025 Q1
Q2 2024 $288,818,000 -$9,552,000 -3.2% 30 Mar 2024 28 Jun 2024 10-Q 31 Jul 2025 2025 Q3
Q1 2024 $364,523,000 -$11,368,000 -3% 30 Dec 2023 29 Mar 2024 10-Q 01 May 2025 2025 Q2
Q4 2023 $315,574,000 -$19,347,000 -5.8% 30 Sep 2023 29 Dec 2023 10-Q 30 Jan 2025 2025 Q1
Q2 2023 $298,370,000 +$8,785,000 +3% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q3
Q1 2023 $375,891,000 +$41,520,000 +12% 31 Dec 2022 31 Mar 2023 10-Q 02 May 2024 2024 Q2
Q4 2022 $334,921,000 -$16,712,000 -4.8% 01 Oct 2022 30 Dec 2022 10-Q 02 Feb 2024 2024 Q1
Q2 2022 $1,260,614,000 $289,585,000 +$2,786,000 +0.97% 02 Apr 2022 01 Jul 2022 10-Q 03 Aug 2023 2023 Q3
Q1 2022 $1,257,828,000 $334,371,000 +$14,813,000 +4.6% 01 Jan 2022 01 Apr 2022 10-Q 05 May 2023 2023 Q2
Q4 2021 $1,243,015,000 $351,633,000 -$38,241,000 -9.8% 25 Sep 2021 31 Dec 2021 10-Q 02 Feb 2023 2023 Q1
Q3 2021 $1,281,256,000 $285,025,000 +$13,834,000 +5.1% 26 Jun 2021 24 Sep 2021 10-K 17 Nov 2021 2021 FY
Q2 2021 $1,267,422,000 $286,799,000 +$39,890,000 +16% 27 Mar 2021 25 Jun 2021 10-Q 09 Aug 2022 2022 Q3
Q1 2021 $1,227,532,000 $319,558,000 -$32,257,000 -9.2% 26 Dec 2020 26 Mar 2021 10-Q 05 May 2022 2022 Q2
Q4 2020 $1,259,789,000 $389,874,000 +$97,997,000 +34% 26 Sep 2020 25 Dec 2020 10-Q 04 Feb 2022 2022 Q1
Q3 2020 $1,161,792,000 $271,191,000 -$27,636,000 -9.2% 27 Jun 2020 25 Sep 2020 10-K 16 Nov 2020 2020 FY
Q2 2020 $1,189,428,000 $246,909,000 -$55,250,000 -18% 28 Mar 2020 26 Jun 2020 10-Q 29 Jul 2021 2021 Q3
Q1 2020 $1,244,678,000 $351,815,000 +$13,557,000 +4% 28 Dec 2019 27 Mar 2020 10-Q 04 May 2021 2021 Q2
Q4 2019 $1,231,121,000 $291,877,000 -$10,499,000 -3.5% 28 Sep 2019 27 Dec 2019 10-Q 29 Jan 2021 2021 Q1
Q3 2019 $1,241,620,000 $298,827,000 +$33,502,000 +13% 29 Jun 2019 27 Sep 2019 10-K 16 Nov 2020 2020 FY
Q2 2019 $1,208,118,000 $302,159,000 +$87,379,000 +41% 30 Mar 2019 28 Jun 2019 10-K 16 Nov 2020 2020 FY
Q1 2019 $1,120,739,000 $338,258,000 +$38,536,000 +13% 29 Dec 2018 29 Mar 2019 10-K 16 Nov 2020 2020 FY
Q4 2018 $1,082,203,000 $302,376,000 +$2,849,000 +0.95% 29 Sep 2018 28 Dec 2018 10-K 16 Nov 2020 2020 FY
Q3 2018 $1,079,354,000 $265,325,000 +$23,277,000 +9.6% 30 Jun 2018 28 Sep 2018 10-K 15 Nov 2018 2018 FY
Q2 2018 $1,056,077,000 $214,780,000 -$90,885,000 -30% 31 Mar 2018 29 Jun 2018 10-Q 02 Aug 2019 2019 Q3
Q1 2018 $1,146,962,000 $299,722,000 +$32,248,000 +12% 30 Dec 2017 30 Mar 2018 10-Q 08 May 2019 2019 Q2
Q4 2017 $1,114,714,000 $299,527,000 +$33,260,000 +12% 30 Sep 2017 29 Dec 2017 10-Q 01 Feb 2019 2019 Q1
Q3 2017 $1,081,454,000 $242,048,000 +$9,051,000 +3.9% 01 Jul 2017 29 Sep 2017 10-K 15 Nov 2018 2018 FY
Q2 2017 $1,072,403,000 $305,665,000 +$28,078,000 +10% 01 Apr 2017 30 Jun 2017 10-K 15 Nov 2018 2018 FY
Q1 2017 $1,044,325,000 $267,474,000 -$6,866,000 -2.5% 31 Dec 2016 31 Mar 2017 10-K 15 Nov 2018 2018 FY
Q4 2016 $1,051,191,000 $266,267,000 +$25,453,000 +11% 01 Oct 2016 30 Dec 2016 10-K 15 Nov 2018 2018 FY
Q3 2016 $1,025,738,000 $232,997,000 +$249,000 +0.11% 02 Jul 2016 30 Sep 2016 10-K 16 Nov 2017 2017 FY
Q2 2016 $1,025,489,000 $277,587,000 +$45,885,000 +20% 02 Apr 2016 01 Jul 2016 10-K 16 Nov 2017 2017 FY
Q1 2016 $979,604,000 $274,340,000 +$2,390,000 +0.88% 02 Jan 2016 01 Apr 2016 10-K 16 Nov 2017 2017 FY
Q4 2015 $977,214,000 $240,814,000 +$6,576,000 +2.8% 26 Sep 2015 01 Jan 2016 10-K 16 Nov 2017 2017 FY
Q3 2015 $970,638,000 $232,748,000 +$5,791,000 +2.6% 27 Jun 2015 25 Sep 2015 10-K 18 Nov 2016 2016 FY
Q2 2015 $964,847,000 $231,702,000 +$8,352,000 +3.7% 28 Mar 2015 26 Jun 2015 10-K 18 Nov 2016 2016 FY
Q1 2015 $956,495,000 $271,950,000 -$6,642,000 -2.4% 27 Dec 2014 27 Mar 2015 10-K 18 Nov 2016 2016 FY
Q4 2014 $963,137,000 $234,238,000 +$2,961,000 +1.3% 27 Sep 2014 26 Dec 2014 10-K 18 Nov 2016 2016 FY
Q3 2014 $960,176,000 $226,957,000 +$10,305,000 +4.8% 28 Jun 2014 26 Sep 2014 10-K 24 Nov 2015 2015 FY
Q2 2014 $949,871,000 $223,350,000 +$16,276,000 +7.9% 29 Mar 2014 27 Jun 2014 10-K 24 Nov 2015 2015 FY
Q1 2014 $933,595,000 $278,592,000 +$29,246,000 +12% 28 Dec 2013 28 Mar 2014 10-K 24 Nov 2015 2015 FY
Q4 2013 $904,349,000 $231,277,000 -$5,325,000 -2.3% 28 Sep 2013 27 Dec 2013 10-K 24 Nov 2015 2015 FY
Q3 2013 $909,674,000 $216,652,000 -$9,103,000 -4% 29 Jun 2013 27 Sep 2013 10-K 18 Nov 2014 2014 FY
Q2 2013 $918,777,000 $207,074,000 -$3,248,000 -1.5% 30 Mar 2013 28 Jun 2013 10-K 18 Nov 2014 2014 FY
Q1 2013 $922,025,000 $249,346,000 -$13,413,000 -5.1% 29 Dec 2012 29 Mar 2013 10-K 18 Nov 2014 2014 FY
Q4 2012 $935,438,000 $236,602,000 +$2,424,000 +1% 29 Sep 2012 28 Dec 2012 10-K 18 Nov 2014 2014 FY
Q3 2012 $933,014,000 $225,755,000 -$18,013,000 -7.4% 30 Jun 2012 28 Sep 2012 10-K 15 Nov 2013 2013 FY
Q2 2012 $951,027,000 $210,322,000 -$8,677,000 -4% 31 Mar 2012 29 Jun 2012 10-K 15 Nov 2013 2013 FY
Q1 2012 $959,704,000 $262,759,000 +$12,733,000 +5.1% 31 Dec 2011 30 Mar 2012 10-K 15 Nov 2013 2013 FY
Q4 2011 $946,971,000 $234,178,000 -$8,534,000 -3.5% 01 Oct 2011 30 Dec 2011 10-K 15 Nov 2013 2013 FY
Q3 2011 $955,505,000 $243,768,000 +$15,961,000 +7% 02 Jul 2011 30 Sep 2011 10-K 15 Nov 2012 2012 FY
Q2 2011 $939,544,000 $218,999,000 -$11,270,000 -4.9% 02 Apr 2011 01 Jul 2011 10-K 15 Nov 2012 2012 FY
Q1 2011 $950,814,000 $250,026,000 +$6,605,000 +2.7% 01 Jan 2011 01 Apr 2011 10-K 15 Nov 2012 2012 FY
Q4 2010 $944,209,000 $242,712,000 25 Sep 2010 31 Dec 2010 10-K 15 Nov 2012 2012 FY
Q3 2010 $227,807,000 26 Jun 2010 24 Sep 2010 10-K 23 Nov 2011 2011 FY
Q2 2010 $230,269,000 27 Mar 2010 25 Jun 2010 10-K 23 Nov 2011 2011 FY
Q1 2010 $243,421,000 26 Dec 2009 26 Mar 2010 10-K 23 Nov 2011 2011 FY

Dolby Laboratories, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 $1,281,256,000 +$119,464,000 +10% 26 Sep 2020 24 Sep 2021 10-K 17 Nov 2021 2021 FY
2020 $1,161,792,000 -$79,828,000 -6.4% 28 Sep 2019 25 Sep 2020 10-K 17 Nov 2021 2021 FY
2019 $1,241,620,000 +$187,020,000 +18% 29 Sep 2018 27 Sep 2019 10-K 17 Nov 2021 2021 FY
2018 $1,054,600,000 -$25,577,000 -2.4% 30 Sep 2017 28 Sep 2018 10-K 16 Nov 2020 2020 FY
2017 $1,080,177,000 +$54,439,000 +5.3% 01 Oct 2016 29 Sep 2017 10-K 25 Nov 2019 2019 FY
2016 $1,025,738,000 +$55,100,000 +5.7% 26 Sep 2015 30 Sep 2016 10-K 15 Nov 2018 2018 FY
2015 $970,638,000 +$10,462,000 +1.1% 27 Sep 2014 25 Sep 2015 10-K 16 Nov 2017 2017 FY
2014 $960,176,000 +$50,502,000 +5.6% 28 Sep 2013 26 Sep 2014 10-K 18 Nov 2016 2016 FY
2013 $909,674,000 -$23,340,000 -2.5% 29 Sep 2012 27 Sep 2013 10-K 24 Nov 2015 2015 FY
2012 $933,014,000 -$28,051,000 -2.9% 01 Oct 2011 28 Sep 2012 10-K 18 Nov 2014 2014 FY
2011 $961,065,000 +$38,352,000 +4.2% 25 Sep 2010 30 Sep 2011 10-K 15 Nov 2013 2013 FY
2010 $922,713,000 26 Sep 2009 24 Sep 2010 10-K 15 Nov 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.